Skip to main content
Erschienen in: Surgical Endoscopy 3/2015

Open Access 01.03.2015

Potential perioperative advantage of colorectal endoscopic submucosal dissection versus laparoscopy-assisted colectomy

verfasst von: Fumihiko Nakamura, Yutaka Saito, Taku Sakamoto, Yosuke Otake, Takeshi Nakajima, Seiichiro Yamamoto, Yoshitaka Murakami, Hideki Ishikawa, Takahisa Matsuda

Erschienen in: Surgical Endoscopy | Ausgabe 3/2015

Abstract

Background

Endoscopic submucosal dissection (ESD) has recently provided a new treatment strategy for large colorectal neoplasms, as an alternative to laparoscopy-assisted colectomy (LAC). Prospective comparative data on the perioperative course of ESD vis-à-vis LAC are scarce.

Methods

We prospectively evaluated the perioperative course of colorectal ESD in 300 patients. We evaluated en bloc and curative resection, procedure duration, postoperative parameters [white blood cell count (WBC), C-reactive protein (CRP), and hemoglobin], pain, recovery duration (time to achieve full mobilization, normal diet, and length of hospitalization), and complications. We also prospectively evaluated 190 patients undergoing LAC as a control group.

Results

The median size of the lesions was 30 mm for ESDs (LACs: 20 mm). The median procedure time was 90 min for ESDs (LACs: 185 min). Postoperative pyrexia was reported in 4 % of ESDs (LACs: 54 %). Only 4 % of ESDs required analgesia (LACs: 61 %). Between the preoperative period and postoperative day 1, the mean difference in WBC and CRP was +1,300/μl for ESDs (LACs: +3,100/μl), and +0.91 mg/dl for ESDs (LACs: +3.96 mg/dl), respectively. A ≥2 g/dl decrease in hemoglobin was observed in 5 % of ESDs (LACs: 30.0 %). Complications were seen in 7 % of ESDs (LACs: 15 %). The rate of delayed bleeding and perforation was 5 and 1.7 % of ESDs, respectively. Although only one of them required laparotomy for peritonitis caused by delayed perforation, others could be managed endoscopically. Additional LAC was required in 16 ESDs due to redefined risk for lymph node metastases. The median hospital stay was 5 days for ESDs (LACs: 10 days). These were consecutive patients with prospective data collection.

Conclusions

Colorectal ESD is effective, minimally invasive and safe in terms of periperative clinical course. Colorectal ESD provides advantages for treatment of large adenomas and early cancers with no risk of lymph node metastasis.
Conventional endoscopic mucosal resection (EMR) is technically inadequate for en bloc resection of early colorectal cancer ≥20 mm. Endoscopic piecemeal mucosal resection is associated with a high incidence of local recurrence or suboptimal estimation of pathological invasion depth [13].
Endoscopic submucosal dissection (ESD) was initially developed for early gastric cancer and facilitates the resection of large superficial tumors en bloc despite the lesion size [48]. The introduction of ESD, consequently, has enabled effective treatment of large colorectal tumors and local recurrent lesion after EMR that would previously have been treated by laparoscopy-assisted colectomy (LAC), not only in Asian countries such as Japan, Korea and China, but also in several western countries [916] (Figs. 1, 2, 3, and 4). Colorectal ESD, however, can take longer to perform than EMR, according to the location or size of the lesions. ESD is, in addition, technical difficult and may also carry the risk of perforation or peritonitis due to the thin muscularis layer of the colon [17].
In many cases outside Japan, LAC, which is less invasive than open surgery, is still performed even if the lesion is a good indication for colorectal ESD. Such lesions include adenoma, with mucosal or shallow submucosal (SM) invasion <1,000 µm from the muscularis mucosae (SM-s), with negligible risk of lymph node metastasis. The standard techniques and safety of LAC have been established, and especially in the colon, it is less invasive and does not adversely affect postoperative quality of life (QOL).
Colorectal ESD, in contrast to LAC or open colectomy, allows intraoperative management by utilizing conscious sedation (midazolam or pentazocine hydrochloride), and does not require general anesthesia with intratracheal intubation. We can, therefore, avoid the risk associated with general anesthesia. Patients who undergo colorectal ESD, in addition, can start walking soon after treatment and achieve early recovery of physical ability. These patients can also resume food intake in the early stage because intestinal tract anastomosis is not required for ESD. Another key factor is that anorectal function can be absolutely preserved in rectal ESD.
We have previously reported that rectal ESD significantly decreases the incidence of local recurrence and preserves postoperative QOL, compared with transanal resection [18]. In Korea, a comparison between ESD and transanal endoscopic microsurgery (TEM), the former was less invasive, although there was no significant difference in clinical outcome between the groups [19]. Rectal ESD has recently been introduced in western countries too [20].
In some industrialized institutions or hospitals, ESD is performed for rectal as well as colonic neoplasms and there are many reports of good safety and clinical outcomes for colorectal ESD.Kiriyama and Saito et al. reported good clinical outcomes for colorectal ESD compared with LAC [21]. There are, however, no data to compare the perioperative clinical course after colorectal ESD and LAC, although several prospective studies on colorectal ESD have been reported. It is important to clarify objectively the invasiveness and safety of colorectal ESD as well as its effectiveness.
The primary indication for colorectal ESD used as a local treatment without lymph node dissection is non-invasive lesions diagnosed as adenoma, mucosal, or SM-s colorectal cancer. The absolute indication for LAC with lymph node dissection is T1 colorectal cancer with deep invasion of the submucosa (SM-d). There are different indications and procedures for the two methods and simple comparison is not possible. Considering the present position, in which LAC is still performed instead of colorectal ESD for lesions with less than SM-s invasion in the world, we decided to compare colorectal ESD with LAC for T1 cancer. We prospectively evaluated the perioperative clinical course of colorectal ESD and LAC. Preoperative diagnostic accuracy was also calculated.

Materials and methods

Patients

We prospectively enrolled ESD patients diagnosed with adenoma or T1 cancer with less than SM-s invasion at the preoperative conference of the Endoscopy Division, National Cancer Center Hospital (NCCH) in Tokyo, Japan, from January 2009 to March 2012. We also prospectively enrolled a control group at the preoperative joint conference between Endoscopy Division and Colorectal Surgery Division in NCCH. This comprised patients who underwent LAC for SM-d cancer (cT1) diagnosed endoscopically or pathologically after endoscopic treatment. Patients who underwent ESD in our institute have the possibility of requiring additional LAC after histological examination of the excised sample. Since this research is observational study and the process until LAC is completed in such case is a series of clinical course on the basis of colorectal ESD, such cases were decided to be included in the ESD group in this study. All patients gave written informed consent for the endoscopic and surgical resections prior to treatment. This study was performed in accordance with the Helsinki Declaration.

Exclusion criteria

Exclusion criteria were: (1) non-neoplastic polyps; (2) familial adenomatous polyposis; or (3) submucosal tumor.

Preoperative diagnosis

Preoperative diagnosis was performed by colonoscopy with magnifying function (CF-HQ290I, CF-H260AZI, PCF-Q240ZI, or PCF-Q260AZI; Olympus Medical Systems Corp., Tokyo, Japan). All lesions were subjected to pit pattern analysis by magnifying chromoendoscopy (MCE) with indigo–carmine dye (0.4 %) and narrow-band imaging (NBI) system. If type V pit pattern was suspected, we also performed estimation by MCE using crystal violet staining (0.05 %). Invasive pattern is used as an index for SM-d cancer [25].

ESD procedure

ESD was carried out with a PCF-Q240JI, PCF-Q260AZI or GIF-Q260J endoscope (Olympus Medical Systems Corp., Tokyo, Japan) equipped with a short type small caliber-tip transparent hood (Fujifilm Corp., Tokyo, Japan) fitted to the tip of the endoscope to retract the SM layer, thereby facilitating dissection. The procedures were primarily performed using a bipolar needle knife (Xeon Medical Corp., Tokyo, Japan) and insulation-tipped knife (Olympus Medical Systems Corp., Tokyo, Japan). Midazolam (2 mg intravenously) and pentazocine hydrochloride (15 mg intravenously) were administered during all ESD procedures. An additional 2 mg midazolam was given as necessary whenever indicated based on the judgment of the colonoscopist. Bipolar hemostatic forceps (Pentax Corp., Tokyo, Japan) were used for hemostasis of bleeding. CO2 insufflation was used instead of air insufflation to reduce patient discomfort. Lesion margins were delineated before ESD using 0.4 % indigo–carmine spray dye. After injection of 10 % glycerol and 5 % fructose in normal saline solution (glycerol; Chugai Pharmaceutical Corp., Tokyo, Japan) and sodium hyaluronate acid (Muco-up; Johnson & Johnson Corp., Tokyo, Japan) into the SM layer, a circumferential incision was made using a bipolar needle knife, and ESD was the performed using one or two ESD knives.

LAC procedure

One of three expert colorectal surgeons performed LAC according to standard procedures with the patient under general anesthesia. Four trocar incisions were used, which were followed by resection of the diseased colon and rectum, a D2 lymph node dissection, and functional end-to-end anastomosis in the colon or double-stapling anastomosis in the rectum. In some patients with tumors located in the lower rectum, temporary ileostomies were performed as the surgeon judged appropriate.

Histopathological assessment

The endoscopically resected specimens, after being fixed in formalin, were sectioned serially at 2–3 mm intervals and the surgically resected specimens at 4–5 mm intervals. Histological diagnosis was based on the Japanese Research Society for Cancer of the Colon and Rectum (JSCCR) and the Vienna classification. Invasion depth of early colorectal cancer was subclassified as adenoma, pTis (M), pT1a (SM-s), pT1b (SM-d) or defined as category 5.1 (intramucosal carcinoma) or category 5.2 (SM carcinoma) according to the Vienna classification of gastrointestinal epithelial neoplasia. The depth of SM tumor invasion was measured between lower muscularis mucosae and the tumor invasive top. If the muscularis mucosae were disrupted by tumor invasion, the depth was measured from the surface of the tumor. In the SM carcinoma, the depth of SM invasion which was <1,000 µm was diagnosed as pT1a (SM-s), while one which was more than 1,000 µm was diagnosed as pT1b (SM-d) in accordance with the JSCCR guideline [22].

Postoperative analysis

We analyzed (1) operation duration, en bloc resection and curative resection; (2) postoperative pyrexia requiring analgesic drugs (non-steroidal anti-inflammatory drugs, pentazocine hydrochloride, or fentanyl), early laboratory investigation, hospitalization, early resumption of normal activities such as walking, drinking and eating; and (3) any complications associated with the procedure.
Curative resection was defined as free margins, SM invasion <1,000 µm from the muscularis mucosae without lymphovascular invasion, a poorly differentiated adenocarcinoma component [22]. ESD procedure time was measured from the initial incision to complete removal of the tumor. LAC procedure time was calculated from the start of the operation to its completion. Analgesic use was related to the presence of postoperative pain, and consisted of non-steroidal anti-inflammatory drugs, pentazocine hydrochloride, or fentanyl. We examined the patients on morning and evening ward rounds as well as reference of their charts to register it prospectively. We validated the results of early laboratory investigations. The mean differences in white blood cell count (WBC) and C-reactive protein (CRP) level between the preoperative period and postoperative day (POD) 1 were calculated. Decreases in hemoglobin level of ≥2 g/dl were noted. We assessed patients for resumption of normal activities such as walking, fluid and food intake, and hospital stay, at round visits and from their chart records. We analyzed complications associated with the procedures. In the ESD group, perforation, penetration, peritonitis, and delayed bleeding were assessed prospectively as major complications and anesthesia complications as minor complications. In the LAC group, major complications (anastomotic leakage, peritonitis, and delayed bleeding) and minor complications (ileus, wound infection and dehiscence, and anesthesia complications) were also analyzed prospectively. The rate of diverting stoma due to postoperative adverse event (perforation, anastomotic leakage, or delayed bleeding) was also considered as a major complication in both groups. Total cases of stoma, in addition, were analyzed.
Preoperative endoscopic diagnostic accuracy was also calculated, excluding the cases in which accurate estimation of histopathological invasion depth of resected specimen were difficult. Accordance between preoperative endoscopic estimation and histopathological invasion depth (M-SM-s or SM-d) was defined as proper diagnosis.

Statistical analysis

Statistical differences were analyzed using the Wilcoxon signed-rank test, Mann–Whitney U test, and χ 2 test. A two-tailed P value below 0.05 was considered statistically significant. Statistical analysis was performed using SPSS for Windows, version 10.1 (SPSS, Chicago, IL, USA).

Results

Patient characteristics

We excluded three cases of non-neoplastic polyps in the ESDs; three cases of familial adenomatous polyposis in the LACs; one case of submucosal tumor in the ESDs. Moreover, two cases in the ESDs for which postoperative information, including blood analysis data, was lacking were excluded in this study term. This left a final total of 300 ESDs that were included in the study. Among these, 16 required additional LAC based on pathological assessment after ESD: one case with SM-s carcinoma with lymphovascular invasion and 15 with SM-d carcinoma.There were 190 cases enrolled in the LACs.
The median age was 68 years in the ESDs (range 36–98 years) and 65 years (20–86 years) in the LACs. The male to female ratio was 1.1:1 in both groups. The median tumor size was 30 mm (range 8–110 mm) in the ESDs and 20 mm (8–150 mm) in the LACs (Table 1).
Table 1
Clinical characteristics of patients
 
No. (%) ESDs
No. (%) LACs
Number
300 (ESD + LAC: 16)
190
Age, median (range), y
68 (36–98)
65 (20–86)
Male
157 (52.3)
101 (53.2)
Size, median (range), mm
30 (8–110)
20 (8–150)
Location (rectum/colon)
83/217 (27.7/72.3)
33/160 (17.4/82.6)
In the ESDs, 232 patients (77.3 %) had laterally spreading tumors (LSTs); these comprised 140 granular LSTs (LST-G) (46.7 %) and 92 non-granular LSTs (LST-NG) (30.7 %). In the LACs, there were 106 non-LSTs (55.8 %) and 19 LSTs (11 LST-G and 8 LST-NG) (10.0 %). Sixty-five (34.2 %) of the operations in the LACs were for post-EMR lesions because of non-curative resection. Twenty (6.7 %) of all ESDs were for local recurrence after previous endoscopic resection. Three cases (1.6 %) of local recurrence required LAC. Two of these were diagnosed as SM-d carcinoma by preoperative colonoscopy at NCCH. The other had lymph vessel invasion diagnosed by histological examination of the resected specimen at the referring hospital.
For histopathological diagnosis, 276 lesions (92.3 %) were adenoma or mucosal to SM-s carcinomas, and 21 lesions (7.0 %) were SM-d carcinomas. Although seven of 21 cases of SM-d carcinomas were suspected at preoperative colonoscopy, ESD was carried out diagnostically in accordance with the age, general status, and wish of the patient. In the LACs, 154 (81.0 %) of all cases were SM-d carcinomas and 34 (17.9 %) were mucosal to SM-s carcinomas. In 34 mucosal and SM-s carcinomas further analysis revealed that 13 cases had lymphovascular infiltration or positive vertical margin (pVM) on pathological analysis after EMR in our hospital or the referring hospital. Four cases did not have an indication for ESD because of invasion to the appendix orifice, and two cases underwent LAC at the outset at the patients’ request. Eight patients were selected for LAC because of large protruding lesions (Paris type 0-Is, >40 mm diameter) such as villous tumors, which were likely to be indicated for multiple piecemeal resection or perforation on preoperative endoscopic examination. Only seven cases were mucosal to SM-s carcinomas, although these were suspected of SM-d carcinomas on preoperative colonoscopy. In two (0.67 %) of the ESDs and two (1.1 %) of the LACs, pathological evaluation was difficult even after retrospective reviews (Table 2).
Table 2
Tumor features (LSTs versus non-LSTs) and pathological tumor depth
 
No. (%) ESDs
(n = 300)
No. (%) LACs
(n = 190)
LSTs
232 (77.3)
19 (10.0)
 Granular
140
11
 Non-granular
92
8
Non-LSTs
68 (22.7)
106 (55.8)
 Protruding
21
24
 Depressed
27
79
 Local recurrence
20
3
 Scar from previous EMR
65 (34.2)
Pathological tumor depth
 M-SM-s
277 (92.3)
34 (17.9)
 SM-d
21 (7.0)
154 (81.0)
 Unknown
2 (0.67)
2 (1.1)
LST laterally spreading tumor, EMR endoscopic submucosal resection, M mucosa, SM-s submucosal invasion <1,000 μm from the muscularis mucosae, SM-d submucosal invasion 1,000 μm or more from the muscularis mucosae

Preoperative endoscopic diagnostic accuracy

In two cases in the ESDs, we were unable to obtain accurate pathological information. Sixty-five cases in the LACs (2 of which also had difficult pathological examination) had scarring from previous EMR. All these cases were excluded from the present analysis.
Preoperative endoscopic diagnostic accuracy on the depth of invasion was 95 % (282/298) in the ESDs and 93 % (116/125) in the LACs. Overall diagnostic accuracy was 94 % (398/423). In the ESDs, 11/298 (3.7 %) cases had additional surgery, because of preoperative estimation of shallow invasion depth. In the LACs, 7/125 (5.6 %) cases turned out to be over surgeries, because of preoperative estimation of deep invasion.

Procedure time and en bloc and curative resection

The median procedure duration in the ESDs was 90 min (range 15–540 min) compared with 185 min (48–499 min) in the LACs (P < 0.001). The en bloc and curative resection rates in the ESDs were 91.7 % (275/300) and 91.0 % (273/300), respectively (Table 3).
Table 3
Clinical outcomes: effectiveness (procedure time, en bloc, and curative resection)
 
No. (%) ESDs
(n = 300)
No. (%) LACs
(n = 190)
P value
Procedure time, median (range), min
90 (15–540)
185 (48–449)
<0.001
En bloc resection
275 (91.7)
 
Curative resectiona
273 (91.0)
 
aCurative resection : free margin, submucosal invasion with <1,000 μm from muscularis mucosae without lymphovascular invasion, a poorly differentiated component

Postoperative pyrexia and early laboratory investigations

The rate of postoperative pyrexia (≥38 °C) was 4.3 % (13/300) in the ESDs, compared with 54.2 % (103/190) in the LACs (P < 0.001). The number of patients requiring analgesic drugs because of postoperative, abdominal or wound pain was 13/300 (4.3 %) in the ESDs and 115/190 (60.5 %) in the LACs (P < 0.001). In the early laboratory investigations, the mean difference in WBC and CRP between the preoperative stage and POD 1 was +1,300/μl in the ESDs and +3,100/μl in the LACs (P < 0.001) and +0.90 mg/dl in the ESDs and +3.96 mg/dl in the LACs (P < 0.001), respectively. In the ESDs, only 11/300 (3.6 %) had decrease in hemoglobin level of ≥2 g/dl, compared with 57/190 (30.0 %) in the LACs (P < 0.001). No transfusions were required the in ESDs, but they were required in the LACs (5/190; 2.6 %) (P = 0.005) (Table 4).
Table 4
Clinical outcomes: less invasiveness (pyrexia, requirement for analgesic drugs, early laboratory investigations, hospitalization, and early resumption of normal activities)
 
No. (%) ESDs
(n = 300)
No. (%) LACs
(n = 190)
P value
Postoperative pyrexia (≥38 °C)
13 (4.3)
103 (54.2)
<0.001
Requiring analgesic drugsa
13 (4.3)
115 (60.5)
<0.001
 Mean variable value of WBC (Pre-op stage/POD1), μl
1,300 (5,900/7,200)
3,100 (5,400/8,500)
<0.001
 Mean variable value of CRP (Pre-op stage/POD1), mg/dl
0.90 (0.13/1.04)
3.96 (0.12/4.08)
<0.001
Rate of drop (≥2 mg/dl) in Hb value
15 (5.0)
57 (30.0)
<0.001
 Transfusion (RCC-LR)
0 (0)
5 (2.6)
0.005
 Hospital stay, median (range), day
5 (4–17)
10 (6–41)
<0.001
 Start of walk, median (range), POD
0 (0–1)
1 (0–2)
<0.001
 Start of drink, median (range), POD
1 (0–4)
1 (1–20)
NS
 Start of diet, median (range), POD
2 (1–6)
3 (1–21)
<0.001
POD post-operative day, Hb hemoglobin, RCC-LR red cell concentrates-leukocytes reduced, NS not significant
aNon-steroidal anti-inflammatory drugs (NSAIDs), pentazocine hydrochloride, or fentanyl

Hospital stay and resumption of normal activities

The median hospital stay in the ESDs was 5 days (range 4–17 days), compared with 10 days (6–41 days) in the LACs (P < 0.001). The median time for a patient who underwent ESD to start walking was POD 0 (range POD 0–1), compared with POD 1 (POD 0–2) in the LACs (P < 0.001). There was no significant difference in the median time for start of fluid intake between the two groups: POD 1 (range POD 0–4) in the ESD group and POD 1 (POD 1–20) in the LACs (P = NS). The median time for start of food intake was POD 2 (range POD 1–6) in the ESDs, and POD 3 (POD 1–21) in the LACs (P < 0.001) (Table 4).

Intra- and postoperative complications

Intra- and postoperative complications were seen in 21 cases (7.0 %) in the ESDs, and in 28 cases (14.7 %) in the LACs (P = 0.005). Delayed bleeding and perforation associated with colorectal ESD was seen in 15 (5.0 %) and five (1.7 %) cases, respectively. All of the cases of delayed bleeding in the ESDs could be cured endoscopically. None of the patients in the ESDs needed a blood transfusion. With regard to perforation, four of five cases were cured by endoscopic clipping and ESD could also be completed. The other case had delayed perforation with acute generalized peritonitis and required emergency surgery. Diverting stoma due to postoperative adverse event was none in the ESDs. There were, in addition, no complications of intravenous anesthesia during ESD.
For major complications in the LACs, three patients (1.6 %) had delayed bleeding, four (2.1 %) had anastomotic leakage, and three (1.6 %) had peritonitis. For minor complication, three each (1.6 %) had wound infection or pneumonitis, two (1.1 %) had postoperative ileus, and one each (0.5 %) had wound dehiscence, subcutaneous hematoma, cholecystitis, paroxysmal atrial fibrillation, hives, or delirium. Three patients (1.6 %) required diverting stoma due to postoperative anastomotic leakage.
Temporal stoma was finally required in three of 16 cases in the ESDs in which additional LAC was performed because SM-d carcinoma or lymphovascular invasion in the lower rectum was confirmed by pathological investigation, while 20 cases (10.5 %) in the LACs required stoma (17 cases and three cases required temporal and permanent stoma, respectively) (P < 0.001) (Table 5).
Table 5
Clinical outcomes: safety (intra and postoperative complications and total cases of stoma)
 
No. (%) ESDs
(n = 300)
No. (%) LACs
(n = 190)
P value
Total
21 (7.0)
28 (14.7)
0.005
Postoperative bleeding
15 (5.0)
3 (1.6)
 
Perforation
5 (1.7)
 
Anastomotic leakage
4 (2.1)
 
Peritonitis
1 (0.3)
3 (1.6)
 
Diverting stoma
0 (0)
3 (1.6)
 
Ileus
0 (0)
2 (1.1)
 
Surgical wound dehiscence
1 (0.5)
 
Surgical wound infection
3 (1.6)
 
Subcutaneous hematoma
1 (0.5)
 
Pneumonitis
0 (0)
3 (1.6)
 
Cholecystitis
0 (0)
1 (0.5)
 
Abdominal incisional hernia
1 (0.5)
 
Hives
0 (0)
1 (0.5)
 
Paroxysmall atrial fibrillation
0 (0)
1 (0.5)
 
Delirium
0 (0)
1 (0.5)
 
Total cases of stoma
3 (1.0)
20 (10.5)
<0.001
Temporal/permanent, No
3/0
17/3
 
These were consecutive patients with prospective data collection.

Discussion

Current status of colorectal ESD—compared with LAC

This is believed to be the first study to evaluate prospectively the clinical outcomes and perioperative clinical course in patients undergoing colorectal ESD and LAC. Simple comparison between ESD and LAC is problematic because each indication differs in Japan, as do procedures. ESD is used as a local treatment without lymph node dissection for adenoma, intramucosal or SM-s carcinomas, whereas LAC is performed for SM-d carcinomas and includes lymph node dissection. Worldwide, however, LAC is performed as the standard for lesions that are a good indication for colorectal ESD in Japan. The reasons are as follows: LAC is a low-invasive procedure compared with laparotomy and maintains QOL [23, 24]. Colorectal ESD, on the other hand, seems to be a difficult and hazardous procedure for non-expert endoscopists.
Endoscopic diagnosis of T stage in early cancer is also a hurdle and controversy, especially in western countries. High diagnostic accuracy of invasion depth of the lesion using magnifying colonoscopy, however, has been reported in Japan. ESD and LAC are selected for cT1a and cT1b, respectively, on the basis of preoperative diagnosis. Good clinical outcome and safety of colorectal ESD have been reported recently in Korea and Japan. Data on the perioperative clinical course and QOL evaluation of colorectal ESD, however, are scant at present. Postoperative QOL assessment for various diseases, in recent years, has been conducted and has become an important part of outcome assessment. The need for minimally invasive treatment to maintain patient QOL has increased. With further dissemination of colorectal ESD in the future, it will be crucial to establish its effectiveness and safety, as well as its minimal invasiveness compared with LAC. Although randomized controlled trials are ideal, their implementation is already difficult in Japan because the indications for colorectal ESD have been established and the technique has become popular.

Characteristics of objective lesions and endoscopic diagnosis—in this study

Looking at the macroscopic type of lesions in this study, LST lesions accounted for 77 % in the ESD group. These lesions are large and difficult to treat by en bloc EMR, but it suggests that LSTs with the features of lateral growth type, which retain within SM-s invasion is an adaptive lesions for most of the colorectal ESD. In the LACs, on the other hand, depressed lesions accompanied with the feature of the likely SM-d invasion accounted for 42 %, even if the lesions were small in size.
Preoperative diagnosis of invasion depth based on conventional and magnifying colonoscopy is therefore important for the choice of ESD or LAC for early colorectal cancer [25]. Although endoscopic ultrasonography (EUS) is also a useful tool for evaluation of lesion depth, magnifying colonoscopy and EUS do not differ significantly for preoperative diagnosis of early colorectal cancer [26]. It is also a major advantage that magnifying colonoscopy can be used regardless of the size and location of the lesion immediately by just touching the zoom lever. In this study, there was a high rate of discrimination of lesion invasion depth by conventional and magnifying colonoscopy and treatment for early colorectal cancer could be selected adequately. If the preoperative diagnostic accuracy was poor and resulted in a high number of non-curative cases that underwent ESD, which then required additional LAC, ESD would not have been developed.
One of the two cases of ESD that had difficulty with histopathological evaluation was resected en bloc by ESD for local recurrence after TEM. In the other case, perforation occurred during ESD. Although endoscopic closure was achieved soon and the ESD procedure was completed, specimen collection was difficult. Adenoma was diagnosed by preoperative colonoscopy in this case and no recurrence was detected after 2.5 years.
Both of the LACs that had difficulty in histopathological evaluation had undergone EMR at another hospital. Although pathological evaluation showed that these cases had SM invasion after EMR, it was difficult to establish the precise depth of invasion according to the unknown orientation of the resected specimen and pVM. Six patients in the ESDs that were diagnosed pathologically as SM-d carcinoma did not receive additional LAC on request of the patients. One of these six patients did not visit our institution for the duration of follow-up. The remaining five cases did not experience any relapse after follow-up of 1.5–3.5 years.

Effectiveness, less invasiveness, and safety—colorectal ESD

Median procedure time of colorectal ESD in this study was half that of LAC. In addition to shorter procedure time, colorectal ESD had high en bloc and curative resection rates. Colorectal ESD, therefore, demonstrated a high rate of effectiveness as a short-term clinical outcome.
With regard to perioperative clinical course, incidence of pyrexia (≥38 °C) and requirement for analgesic drugs were initially significantly lower for ESDs than LACs. This reflects the advantage of colorectal ESD; it can complete local resection of the intestinal, mucosal, and SM layers without laparotomy and interperitoneal procedures, including lymph node dissection.
We also investigated changes in WBC, CRP, and hemoglobin value between the preoperative period and POD 1. Variations in the inflammatory response indicators (WBC and CRP) were insignificant in the ESDs. Also, only 4 % of the ESD group had a ≥2 g/dl decrease in hemoglobin level. These absolute objective data indicate that ESD is less invasive than LAC. The reasons why the decrease in hemoglobin was low in the ESDs were the small amount of bleeding and immediate hemostasis during colorectal ESD.
Hospital stay in the ESDs was half that of the LACs. The time to resume fluid and food intake in the ESDs was POD 1 and POD 2, respectively. Although fluid intake in the ESDs started at almost the same time as in the LACs, food intake in the ESDs was significantly earlier. The median time to start walking was POD 0 in the ESDs. This indicated that patients could start walking soon after the procedure and this is one important factor associated with the lower level of invasiveness of colorectal ESD compared with LAC. Considering the lesser invasiveness of colorectal ESD, although hospital stay was 5 days in this study according to the clinical pathway which concerns the standardization of care process, day surgery may not be impossible [27].
The rate of major and minor complications with ESDs was 7.0 %. This was lower than with LACs, which is an established method of treatment worldwide. In four of five patients in the ESDs with perforation, complete closure was achieved utilizing an endoscopic clip (the other case required emergency ileo-cecal resection because of delayed perforation). A stable clinical course after the closure for perforation was achieved on the basis of conservative therapy such as fasting, hydration, and antibiotics. ESD has the following attributes for the management of perforation: (1) perforation occurs during the procedure, endoscopic closure using a clip can be achieved because the diameter of perforation is small compared to those by EMR; and (2) sufficient preparation can help the endoscopic management and prevent severe peritonitis.
The rate of delayed bleeding with ESD was higher than with LAC. Endoscopic hemostasis, however, could be achieved in all cases and no transfusions were required in the ESDs. In the LACs, there were three cases of delayed bleeding and two of them required blood transfusion; endoscopic and surgical hemostasis was required in one case each. The other case had a coexistent anastomotic leakage and required diverting stoma. Physical stress caused by delayed bleeding in ESD patients is lower than for LAC patients because it is only a minor factor and transfusion is not necessary in ESD. This is probably because ESD were conducted with coagulation of all exposed vessels in SM layer during and after the procedures.
Our results indicate the safety of colorectal ESD, because procedural complications such as delayed bleeding and perforation could be managed endoscopically, and there were no anesthesia complications. We should, however, pay attention to delayed perforation because emergency surgery is not preventable even though the incidence is quite low. Excess heating of endoscopic devices against the intestinal layer, which can lead to perforation, should be avoided so we prefer to use mainly bipolar devices and we should repair any damage to the muscularis layer by careful endoscopic clipping. These procedures are essential to prevent delayed perforation.
Stoma is associated with postoperative QOL but was only required in three cases (1.0 %), with additional LAC after ESD. In contrast, it was required in 20 cases (10.5 %) in the LACs. ESD enabled patients to maintain perioperative QOL with regard to anorectal function.

Problem points and management guide of colorectal ESD

The technical difficulty and complications of ESD preclude the standardization of this novel procedure. Colorectal ESD, at present, is only practiced in Japan, Korea, and a few facilities in other countries. To overcome these obstacles, it is necessary to undergo ESD training using animal models and to accumulate experience of basic procedures such as endoscope insertion and EMR. The delay in applying ESD devices that are used exclusively in Japan is one of the hurdles in the dissemination of ESD overseas.
According to our study, rectal ESD is easier to perform than cecal ESD. The latter is likely to be difficult technically because the cecum is located in the innermost part of the large intestine and its wall is thin. The risk of perforation in the lower rectum is lower and there is better access for the endoscope and other devices. Rectal LAC is, paradoxically, more difficult because the pelvic cavity is anatomically narrow, surgical injuries tend to be more serious in lower rectal LAC. Temporary or permanent stomas are also necessary in some rectal LAC cases, despite the early stage nature of the lesions. Cecal LAC, in contrast, is easier to perform [21]. To decide on selection of treatment method (ESD or LAC), we should consider the following as well as preoperative endoscopic diagnosis: skill of the operator, reputation of the institution, and invasiveness for the patient. We should conduct diagnostic rectal ESD, to some extent aggressively, even if the lesion is all circumferential, or the differential diagnosis is difficult between SM-s and SM-d carcinoma by preoperative colonoscopy. We should, in contrast, select cecal LAC if cecal ESD is difficult to perform, in accordance with the endoscopist’s skill level.
Patient safety and accurate pathological assessment are important in terms of prognosis. If completion of ESD is difficult, we should stop the procedure and covert to LAC. This would enable us to avoid the complications of ESD and multiple piecemeal resection, which is associated with a high incidence of local recurrence or residual lesions [3]. Adequate additional surgery cannot be performed if the degree of SM invasion or lymphovascular invasion is suboptimal because of multiple piecemeal resection.
Our study had the following limitation. This was a single center study and the postoperative clinical course of colorectal ESD and LAC was based on the clinical pathway of our institution. Thus, a future multicenter study is required.
In conclusion, colorectal ESD is an effective technique with a short procedure time, high rate of curative resection, and procedural safety, as well as being less invasive than LAC. It is expected that colorectal ESD will continue to spread worldwide in the future with the development of endoscopic devices and simplification of treatment. Also, we should not forget that patients always request the less invasive, safe and adequate treatment.

Disclosures

No conflict interest has been declared by F. Nakamura, Y. Saito, T. Sakamoto, Y. Otake, T. Nakajima, S. Yamamoto, Y. Murakami, H. Ishikawa, and T. Matsuda.

Funding information

This prospective study was partially supported by National Cancer Center Research and Development Fund (23-A-19 and 25-A-12) to Dr. Saito. The other authors disclosed no financial relationships relevant to this publication.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Literatur
1.
Zurück zum Zitat Saito Y, Fukuzawa M, Matsuda T, Fukunaga S, Sakamoto T, Uraoka T, Nakajima T, Ikehara H, Fu KI, Itoi T, Fjii T (2010) Clinical outcome of endoscopic submucosal dissection versus endoscopic mucosal resection of large colorectal tumors as determined by curative resection. Surg Endosc 24:343–352PubMedCrossRef Saito Y, Fukuzawa M, Matsuda T, Fukunaga S, Sakamoto T, Uraoka T, Nakajima T, Ikehara H, Fu KI, Itoi T, Fjii T (2010) Clinical outcome of endoscopic submucosal dissection versus endoscopic mucosal resection of large colorectal tumors as determined by curative resection. Surg Endosc 24:343–352PubMedCrossRef
2.
Zurück zum Zitat Tanaka S, Haruma K, Oka S, Takahashi R, Kunihiro M, Kitadai Y, Yoshihara M, Shimamoto F, Chayama K (2001) Clinicopathologic features and endoscopic treatment of superficially spreading colorectal neoplasms larger than 20 mm. Gastrointest Endosc 54:62–66PubMedCrossRef Tanaka S, Haruma K, Oka S, Takahashi R, Kunihiro M, Kitadai Y, Yoshihara M, Shimamoto F, Chayama K (2001) Clinicopathologic features and endoscopic treatment of superficially spreading colorectal neoplasms larger than 20 mm. Gastrointest Endosc 54:62–66PubMedCrossRef
3.
Zurück zum Zitat Sakamoto T, Matsuda T, Otake Y, Nakajima T, Saito Y (2012) Predictive factors of local recurrence after endoscopic piecemeal mucosal resection. J Gastroenterol 47:635–640PubMedCrossRef Sakamoto T, Matsuda T, Otake Y, Nakajima T, Saito Y (2012) Predictive factors of local recurrence after endoscopic piecemeal mucosal resection. J Gastroenterol 47:635–640PubMedCrossRef
4.
Zurück zum Zitat Hosokawa K, Yoshida S (1998) Recent advances in endoscopic mucosal resection for early gastric cancer. Jpn J Cancer Chemother 25:476–483 Hosokawa K, Yoshida S (1998) Recent advances in endoscopic mucosal resection for early gastric cancer. Jpn J Cancer Chemother 25:476–483
5.
Zurück zum Zitat Ohkuwa M, Hosokawa N, Boku N, Ohtsu H, Tajiri S, Yoshida S (2001) New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy 33:221–226PubMedCrossRef Ohkuwa M, Hosokawa N, Boku N, Ohtsu H, Tajiri S, Yoshida S (2001) New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy 33:221–226PubMedCrossRef
6.
Zurück zum Zitat Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S (2001) Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48:225–229PubMedCentralPubMedCrossRef Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S (2001) Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48:225–229PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Kondo H, Gotoda T, Ono H, Oda I, Kozu T, Fujishiro M, Saito D, Yoshida S (2004) Percutaneous traction-assisted EMR by using an insulation-tipped electrosurgical knife for early stage gastric cancer. Gastrointest Endosc 59:284–288PubMedCrossRef Kondo H, Gotoda T, Ono H, Oda I, Kozu T, Fujishiro M, Saito D, Yoshida S (2004) Percutaneous traction-assisted EMR by using an insulation-tipped electrosurgical knife for early stage gastric cancer. Gastrointest Endosc 59:284–288PubMedCrossRef
8.
Zurück zum Zitat Kobayashi T, Gotohda T, Tamakawa K, Ueda H, Kakizoe T (2004) Magnetic anchor for more effective endoscopic mucosal resection. Jpn J Clin Oncol 34:118–123PubMedCrossRef Kobayashi T, Gotohda T, Tamakawa K, Ueda H, Kakizoe T (2004) Magnetic anchor for more effective endoscopic mucosal resection. Jpn J Clin Oncol 34:118–123PubMedCrossRef
9.
Zurück zum Zitat Yamamoto H (2005) Endoscopic submucosal dissection of early cancers and large flat adenomas. Clin Gastroenterol Hepatol 3(7 Suppl 1):S74–S76PubMedCrossRef Yamamoto H (2005) Endoscopic submucosal dissection of early cancers and large flat adenomas. Clin Gastroenterol Hepatol 3(7 Suppl 1):S74–S76PubMedCrossRef
10.
Zurück zum Zitat Gotoda T, Kondo H, Ono H, Saito Y, Yamaguchi H, Saito D, Yokota T (1999) A new endoscopic resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc 50:560–563PubMedCrossRef Gotoda T, Kondo H, Ono H, Saito Y, Yamaguchi H, Saito D, Yokota T (1999) A new endoscopic resection procedure using an insulation-tipped electrosurgical knife for rectal flat lesions: report of two cases. Gastrointest Endosc 50:560–563PubMedCrossRef
11.
Zurück zum Zitat Yamamoto H, Kawata H, Sunada K, Sasaki A, Nakazawa K, Miyata T, Sekine Y, Yano T, Satoh K, Ido K, Sugano K (2003) Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood. Endoscopy 35:690–694PubMedCrossRef Yamamoto H, Kawata H, Sunada K, Sasaki A, Nakazawa K, Miyata T, Sekine Y, Yano T, Satoh K, Ido K, Sugano K (2003) Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood. Endoscopy 35:690–694PubMedCrossRef
12.
Zurück zum Zitat Saito Y, Emura F, Matsuda T, Uraoka T, Nakajima T, Ikematsu H, Gotoda T, Saito D, Fujii T (2005) A new sinker-assisted endoscopic submucosal dissection for colorectal cancer. Gastrointest Endosc 62:297–301PubMedCrossRef Saito Y, Emura F, Matsuda T, Uraoka T, Nakajima T, Ikematsu H, Gotoda T, Saito D, Fujii T (2005) A new sinker-assisted endoscopic submucosal dissection for colorectal cancer. Gastrointest Endosc 62:297–301PubMedCrossRef
13.
Zurück zum Zitat Sano Y, Fu KI, Saito Y, Doi T, Hanafusa M, Fujii S, Fujimori T, Ohtsu A (2006) A newly developed bipolar-current needle-knife for endoscopic submucosal dissection of large colorectal tumors. Endoscopy 38(suppl 2):E95PubMedCrossRef Sano Y, Fu KI, Saito Y, Doi T, Hanafusa M, Fujii S, Fujimori T, Ohtsu A (2006) A newly developed bipolar-current needle-knife for endoscopic submucosal dissection of large colorectal tumors. Endoscopy 38(suppl 2):E95PubMedCrossRef
14.
Zurück zum Zitat Saito Y, Uraoka T, Matsuda T, Emura F, Ikehara H, Mashimo Y, Kikuchi T, Kozu T, Saito D (2007) A pilot study to assess safety and efficacy of carbon dioxide insufflation during colorectal endoscopic submucosal dissection with the patient under conscious sedation. Gastrointest Endosc 65:537–542PubMedCrossRef Saito Y, Uraoka T, Matsuda T, Emura F, Ikehara H, Mashimo Y, Kikuchi T, Kozu T, Saito D (2007) A pilot study to assess safety and efficacy of carbon dioxide insufflation during colorectal endoscopic submucosal dissection with the patient under conscious sedation. Gastrointest Endosc 65:537–542PubMedCrossRef
15.
Zurück zum Zitat Saito Y, Uraoka T, Matsuda T, Emura F, Ikehara H, Mashimo Y, Kikuchi T, Fu kI, Sano Y, Saito D (2007) Endoscopic treatment of large superficial colorectal tumors: a case series of 200 endoscopic submucosal dissections (with video). Gastrointest Endosc 66:966–973PubMedCrossRef Saito Y, Uraoka T, Matsuda T, Emura F, Ikehara H, Mashimo Y, Kikuchi T, Fu kI, Sano Y, Saito D (2007) Endoscopic treatment of large superficial colorectal tumors: a case series of 200 endoscopic submucosal dissections (with video). Gastrointest Endosc 66:966–973PubMedCrossRef
16.
Zurück zum Zitat Uraoka T, Saito Y, Matsuda T, Ikehara H, Gotoda T, Saito D, Fujii T (2006) Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut 55:1592–1597PubMedCentralPubMedCrossRef Uraoka T, Saito Y, Matsuda T, Ikehara H, Gotoda T, Saito D, Fujii T (2006) Endoscopic indications for endoscopic mucosal resection of laterally spreading tumours in the colorectum. Gut 55:1592–1597PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Saito Y, Uraoka T, Yamaguchi Y, Hotta K, Sakamoto N, Ikematsu H, Fukuzawa M, Kobayashi N, Nasu J, Michida T, Yoshida S, Ikehara H, Otake Y, Nakajima T, Matsuda T, Saito D (2010) A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissecions (with video). Gastrointest Endosc 72:1217–1225PubMedCrossRef Saito Y, Uraoka T, Yamaguchi Y, Hotta K, Sakamoto N, Ikematsu H, Fukuzawa M, Kobayashi N, Nasu J, Michida T, Yoshida S, Ikehara H, Otake Y, Nakajima T, Matsuda T, Saito D (2010) A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissecions (with video). Gastrointest Endosc 72:1217–1225PubMedCrossRef
18.
Zurück zum Zitat Kiriyama S, Saito Y, Matsuda T, Nakajima T, Mashimo Y, Joeng HK, Moriya Y, Kuwano H (2011) Comparing endoscopic submucosal dissection with transanal resection for non-invasive rectal tumor: a retrospective study. J Gastroenterol Hepatol 26:1028–1033PubMedCrossRef Kiriyama S, Saito Y, Matsuda T, Nakajima T, Mashimo Y, Joeng HK, Moriya Y, Kuwano H (2011) Comparing endoscopic submucosal dissection with transanal resection for non-invasive rectal tumor: a retrospective study. J Gastroenterol Hepatol 26:1028–1033PubMedCrossRef
19.
Zurück zum Zitat Park SU, Min YW, Shin JU, Choi JH, Kim YH, Kim JJ, Cho YB, Kim HC, Yun SH, Lee WY, Chun HK, Chang DK (2012) Endoscopic submucosal dissection or transanal endoscopic microsurgery for nonpolypoid rectal high grade dysplasia and submucosa-invading rectal cancer. Endoscopy 44:1031–1036PubMedCrossRef Park SU, Min YW, Shin JU, Choi JH, Kim YH, Kim JJ, Cho YB, Kim HC, Yun SH, Lee WY, Chun HK, Chang DK (2012) Endoscopic submucosal dissection or transanal endoscopic microsurgery for nonpolypoid rectal high grade dysplasia and submucosa-invading rectal cancer. Endoscopy 44:1031–1036PubMedCrossRef
20.
Zurück zum Zitat Repici A, Hassan C, Pagano N, Rando G, Romeo F, Spaggiari P, Roncalli M, Rerrara E, Malesci A (2013) High efficacy of endoscopic submucoal dissection for rectal laterally spreading tumors larger than 3 cm. Gatrointest Endosc 77:96–101CrossRef Repici A, Hassan C, Pagano N, Rando G, Romeo F, Spaggiari P, Roncalli M, Rerrara E, Malesci A (2013) High efficacy of endoscopic submucoal dissection for rectal laterally spreading tumors larger than 3 cm. Gatrointest Endosc 77:96–101CrossRef
21.
Zurück zum Zitat Kiriyama S, Saito Y, Yamamoto S, Soetikno R, Matsuda T, Nakajima T, Kuwano H (2012) Comparison of endoscopic submucosal dissection with laparoscopic-assisted colorectal surgery for early-stage colorectal cancer: a retrospective analysis. Endoscopy 44:1024–1030PubMedCrossRef Kiriyama S, Saito Y, Yamamoto S, Soetikno R, Matsuda T, Nakajima T, Kuwano H (2012) Comparison of endoscopic submucosal dissection with laparoscopic-assisted colorectal surgery for early-stage colorectal cancer: a retrospective analysis. Endoscopy 44:1024–1030PubMedCrossRef
22.
Zurück zum Zitat Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K (2012) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17:1–29PubMedCrossRef Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K (2012) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17:1–29PubMedCrossRef
23.
Zurück zum Zitat Velanovich V (2000) Laparoscopic vs open surgery—a preliminary comparison of quality-of-life outcomes. Surg Endosc 14:16–21PubMedCrossRef Velanovich V (2000) Laparoscopic vs open surgery—a preliminary comparison of quality-of-life outcomes. Surg Endosc 14:16–21PubMedCrossRef
24.
Zurück zum Zitat Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G (2002) Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA 287:321–327PubMedCrossRef Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G (2002) Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA 287:321–327PubMedCrossRef
25.
Zurück zum Zitat Matsuda T, Fujii T, Saito Y, Nakajima T, Uraoka T, Kobayashi N, Ikehara H, Ikematsu H, Fu KI, Emura F, Ono A, Sano Y, Shimoda T, Fujimori T (2008) Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol 103:2700–2706PubMedCrossRef Matsuda T, Fujii T, Saito Y, Nakajima T, Uraoka T, Kobayashi N, Ikehara H, Ikematsu H, Fu KI, Emura F, Ono A, Sano Y, Shimoda T, Fujimori T (2008) Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol 103:2700–2706PubMedCrossRef
26.
Zurück zum Zitat Fu KI, Kato S, Sano Y, Onuma EK, Saito Y, Matsuda T, Koba I, Yoshida S, Fujii T (2008) Staging of early colorectal cancer: magnifying colonoscopy versus endoscopic ultrasonography for estimation of depth of invasion. Dig Dis Sci 53:1886–1892PubMedCrossRef Fu KI, Kato S, Sano Y, Onuma EK, Saito Y, Matsuda T, Koba I, Yoshida S, Fujii T (2008) Staging of early colorectal cancer: magnifying colonoscopy versus endoscopic ultrasonography for estimation of depth of invasion. Dig Dis Sci 53:1886–1892PubMedCrossRef
27.
Zurück zum Zitat Aoki T, Nakajima T, Saito Y, Matsuda T, Sakamoto T, Itoi T, Khiyar Y, Moriyasu F (2012) Assessment of the validity of the clinical pathway for colon endoscopic submucosal dissection. World J Gastroenterol 18:3721–3726PubMedCentralPubMedCrossRef Aoki T, Nakajima T, Saito Y, Matsuda T, Sakamoto T, Itoi T, Khiyar Y, Moriyasu F (2012) Assessment of the validity of the clinical pathway for colon endoscopic submucosal dissection. World J Gastroenterol 18:3721–3726PubMedCentralPubMedCrossRef
Metadaten
Titel
Potential perioperative advantage of colorectal endoscopic submucosal dissection versus laparoscopy-assisted colectomy
verfasst von
Fumihiko Nakamura
Yutaka Saito
Taku Sakamoto
Yosuke Otake
Takeshi Nakajima
Seiichiro Yamamoto
Yoshitaka Murakami
Hideki Ishikawa
Takahisa Matsuda
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 3/2015
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-014-3705-5

Weitere Artikel der Ausgabe 3/2015

Surgical Endoscopy 3/2015 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.